source
- CinRx partners with Graviton Bioscience to target ROCK2 in pulmonary arterial hypertension and other cardiovascular diseasesCinRx announced a collaboration with Graviton Bioscience, led by Sam Waksal, to develop therapies that inhibit the ROCK2 enzyme. The partnership will focus on pulmonary arterial hypertension (PAH)…
- Early Alert: B. Braun Medical Inc. Removes Streamline Bloodline Set for Dialog+The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood loss.